Table.
Reported Cases of Percutaneous Transhepatic SEMS Placement for Malignant ALO.
| Case | Reference | Year | Age (y) | Gender | Etiology | Reconstruction | SEMS | Delivery |
|---|---|---|---|---|---|---|---|---|
| 1 | 7 | 2000 | 65 | M | Gastric cancer | NA | Wallstent 22×100 mm, (uncovered) | 10Fr |
| 2 | 8 | 2000 | 47 | M | Gastric cancer | Roux-en-Y | Wallstent 10×70 mm (uncovered) | NA |
| 3 | 9 | 2003 | 62 | M | Pancreatic cancer | Whipple | Wallstent NA×60 mm (uncovered) | 10Fr |
| 4 | 10 | 2005 | 77 | M | Gastric cancer | Billroth II | SMART stent 10×80 mm SMART stent 10×40 mm (uncovered) |
7Fr×2 |
| 5 | 11 | 2007 | 46 | F | Gastric cancer | Billroth II | Nitinol SEMS 18×80 mm (partially covered) | 12Fr |
| 6 | 11 | 2007 | 60 | M | Gastric cancer | Billroth II | Nitinol SEMS 18×80 mm, (partially covered) | 12Fr |
| 7 | 6 | 2010 | 71 | M | Ampullary carcinoma | Whipple | ComVi 22×100 mm (covered) | 10.5Fr |
| 8 | 12 | 2012 | 51 | M | Ampullary carcinoma | Child | WallFlex 22×120 mm (uncovered) | 10Fr |
| 9 | Current case | 2017 | 71 | M | Gastric cancer | Roux-en-Y | WallFlex 22×90 mm (uncovered) | 10Fr |